Assessment of markers of inflammation and neuronal damage in patients with autism spectrum disorders associated with genetic deficiency of the folate cycle
Keywords:
immunodiagnostics, immunotherapy, neuropsychiatric disorders, children, diagnostics, therapySynopsis
Autism spectrum disorders (ASD) currently occur in at least 1 % of children in the modern population, and the trend towards an increase in the frequency of this psychiatric pathology among the pediatric population continues. Although more than 100 genetic causes of the ASD phenotype in children have been proposed, most of them are rare and do not significantly affect either the high prevalence of the disease or the trend towards an increase in the frequency of these disorders in the population. Genetic deficiency of the folate cycle (GDFC) is a fairly common pathology of the human genome, which may explain the current epidemiological features of ASD. The evidence base for the association of GDFC and ASD in children is based on the results of 5 meta-analyses of randomized controlled clinical trials conducted from 2013 to 2020 and covering the results of 8 to 25 trials involving 1361 to more than 3000 children with ASD and 6591 to 7257 healthy children. It has been established that GDFC leads to the development of a number of pathological biochemical changes in the body, including hyperhomocysteinemia, which predispose to the development of oxidative stress.
References
Maltsev, D. V. (2018). Evaluation of the immune status in children with autism spectrum disorders associated with genetic folate cycle deficiency. Likarska Sprava, 1-2, 11–23. https://doi.org/10.31640/jvd.1-2.2018(02)
Maltcev, D. V., Natrus, L. V. (2020). The Effectiveness of Infliximab in Autism Spectrum Disorders Associated with Folate Cycle Genetic Deficiency. Psychiatry, Psychotherapy and Clinical Psychology, 3, 583–594. https://doi.org/10.34883/pi.2020.11.3.015
Bhatia, P., Singh, N. (2015). Homocysteine excess: delineating the possible mechanism of neurotoxicity and depression. Fundamental & Clinical Pharmacology, 29 (6), 522–528. https://doi.org/10.1111/fcp.12145
Binstock, T. (2001). Intra-monocyte pathogens delineate autism subgroups. Medical Hypotheses, 56 (4), 523–531. https://doi.org/10.1054/mehy.2000.1247
Cabanlit, M., Wills, S., Goines, P., Ashwood, P., Van de Water, J. (2007). Brain‐Specific Autoantibodies in the Plasma of Subjects with Autistic Spectrum Disorder. Annals of the New York Academy of Sciences, 1107 (1), 92–103. https://doi.org/10.1196/annals.1381.010
Chen, L., Shi, X.-J., Liu, H., Mao, X., Gui, L.-N., Wang, H., Cheng, Y. (2021). Oxidative stress marker aberrations in children with autism spectrum disorder: a systematic review and meta-analysis of 87 studies (N = 9109). Translational Psychiatry, 11 (1). https://doi.org/10.1038/s41398-020-01135-3
Crawley, J. N., Heyer, W.-D., LaSalle, J. M. (2016). Autism and Cancer Share Risk Genes, Pathways, and Drug Targets. Trends in Genetics, 32 (3), 139–146. https://doi.org/10.1016/j.tig.2016.01.001
Frustaci, A., Neri, M., Cesario, A., Adams, J. B., Domenici, E., Dalla Bernardina, B., Bonassi, S. (2012). Oxidative stress-related biomarkers in autism: Systematic review and meta-analyses. Free Radical Biology and Medicine, 52 (10), 2128–2141. https://doi.org/10.1016/j.freeradbiomed.2012.03.011
Frye, R. E., Sequeira, J. M., Quadros, E. V., James, S. J., Rossignol, D. A. (2012). Cerebral folate receptor autoantibodies in autism spectrum disorder. Molecular Psychiatry, 18 (3), 369–381. https://doi.org/10.1038/mp.2011.175
Furlano, R. I., Anthony, A., Day, R., Brown, A., McGarvey, L., Thomson, M. A. et al. (2001). Colonic CD8 and γδ T-cell infiltration with epithelial damage in children with autism. The Journal of Pediatrics, 138 (3), 366–372. https://doi.org/10.1067/mpd.2001.111323
Guo, B.-Q., Li, H.-B., Ding, S.-B. (2020). Blood homocysteine levels in children with autism spectrum disorder: An updated systematic review and meta-analysis. Psychiatry Research, 291, 113283. https://doi.org/10.1016/j.psychres.2020.113283
Li, H., Liu, H., Chen, X., Zhang, J., Tong, G., Sun, Y. (2020). Association of food hypersensitivity in children with the risk of autism spectrum disorder: a meta-analysis. European Journal of Pediatrics, 180 (4), 999–1008. https://doi.org/10.1007/s00431-020-03826-x
Li, Y., Qiu, S., Shi, J., Guo, Y., Li, Z., Cheng, Y., Liu, Y. (2020). Association between MTHFR C677T/A1298C and susceptibility to autism spectrum disorders: a meta-analysis. BMC Pediatrics, 20 (1). https://doi.org/10.1186/s12887-020-02330-3
Lv, M., Zhang, H., Shu, Y., Chen, S., Hu, Y., Zhou, M. (2016). The neonatal levels of TSB, NSE and CK-BB in autism spectrum disorder from Southern China. Translational Neuroscience, 7 (1), 6–11. https://doi.org/10.1515/tnsci-2016-0002
Masi, A., Quintana, D. S., Glozier, N., Lloyd, A. R., Hickie, I. B., Guastella, A. J. (2014). Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Molecular Psychiatry, 20 (4), 440–446. https://doi.org/10.1038/mp.2014.59
Mead, J., Ashwood, P. (2015). Evidence supporting an altered immune response in ASD. Immunology Letters, 163 (1), 49–55. https://doi.org/10.1016/j.imlet.2014.11.006
Shaik Mohammad, N., Sai Shruti, P., Bharathi, V., Krishna Prasad, C., Hussain, T., Alrokayan, S. A. et al. (2016). Clinical utility of folate pathway genetic polymorphisms in the diagnosis of autism spectrum disorders. Psychiatric Genetics, 26 (6), 281–286. https://doi.org/10.1097/ypg.0000000000000152
Nicolson, G. L., Gan, R., Nicolson, N. L., Haier, J. (2007). Evidence for Mycoplasma ssp., Chlamydia pneunomiae, and human herpes virus‐6 coinfections in the blood of patients with autistic spectrum disorders. Journal of Neuroscience Research, 85 (5), 1143–1148. https://doi.org/10.1002/jnr.21203
Noriega, D. B., Savelkoul, H. F. J. (2013). Immune dysregulation in autism spectrum disorder. European Journal of Pediatrics, 173 (1), 33–43. https://doi.org/10.1007/s00431-013-2183-4
Pu, D., Shen, Y., Wu, J. (2013). Association between MTHFR Gene Polymorphisms and the Risk of Autism Spectrum Disorders: A Meta‐Analysis. Autism Research, 6 (5), 384–392. https://doi.org/10.1002/aur.1300
Rai, V. (2016). Association of methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism with autism: evidence of genetic susceptibility. Metabolic Brain Disease, 31 (4), 727–735. https://doi.org/10.1007/s11011-016-9815-0
Sadeghiyeh, T., Dastgheib, S. A., Mirzaee-Khoramabadi, K., Morovati-Sharifabad, M., Akbarian-Bafghi, M. J., Poursharif, Z. et al. (2019). Association of MTHFR 677C>T and 1298A>C polymorphisms with susceptibility to autism: A systematic review and meta-analysis. Asian Journal of Psychiatry, 46, 54–61. https://doi.org/10.1016/j.ajp.2019.09.016
Saghazadeh, A., Ataeinia, B., Keynejad, K., Abdolalizadeh, A., Hirbod-Mobarakeh, A., Rezaei, N. (2019). A meta-analysis of pro-inflammatory cytokines in autism spectrum disorders: Effects of age, gender, and latitude. Journal of Psychiatric Research, 115, 90–102. https://doi.org/10.1016/j.jpsychires.2019.05.019
Torrente, F., Ashwood, P., Day, R., Machado, N., Furlano, R. I., Anthony, A. et al. (2002). Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Molecular Psychiatry, 7 (4), 375–382. https://doi.org/10.1038/sj.mp.4001077
Wang, Z., Ding, R., Wang, J. (2020). The Association between Vitamin D Status and Autism Spectrum Disorder (ASD): A Systematic Review and Meta-Analysis. Nutrients, 13 (1), 86. https://doi.org/10.3390/nu13010086
Yektaş, Ç., Alpay, M., Tufan, A. E. (2019). Comparison of serum B12, folate and homocysteine concentrations in children with autism spectrum disorder or attention deficit hyperactivity disorder and healthy controls. Neuropsychiatric Disease and Treatment, 15, 2213–2219. https://doi.org/10.2147/ndt.s212361
Zheng, Z., Zheng, P., Zou, X. (2020). Peripheral Blood S100B Levels in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis. Journal of Autism and Developmental Disorders, 51 (8), 2569–2577. https://doi.org/10.1007/s10803-020-04710-1
Downloads
Pages
83-91
Published
May 19, 2025
Categories
Copyright (c) 2025 Dmytro Maltsev
Details about the available publication format: PDF
PDF
ISBN-13 (15)
978-617-8360-21-4
How to Cite
Assessment of markers of inflammation and neuronal damage in patients with autism spectrum disorders associated with genetic deficiency of the folate cycle. (2025). In D. Maltsev, IMMUNODIAGNOSTICS AND IMMUNOTHERAPY OF NEUROPSYCHIATRIC DISORDERS IN CHILDREN (pp. 83–91). Kharkiv: TECHNOLOGY CENTER PC. https://doi.org/10.15587/978-617-8360-21-4.ch6
